Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

US And Canada

EnerVenue electrifies $100m series A
Stanford University has backed a round that will help the nickel-hydrogen battery developer finance construction of a Gigafactory.
Daily deal net: September 15, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Louisville launches UofL Ventures
Will Metcalf will lead the office, which will be located within University of Louisville’s Office of Research and Innovation.
Context Therapeutics frames IPO plans
Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.
Vanqua Bio wins over series B investors
Osage University Partners is among the investors in Northwestern spinout Vanqua Bio’s $85m series B round.
AgBiome cultivates $116m series D
UNC Chapel Hill’s agricultural technology developer AgBiome has increased its overall funding to $230m following the series D round.
Daily deal net: September 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Prospection delves into $33m series B
Main Sequence Ventures has returned for Prospection’s series B round, having already participated in the company’s $6.7m series A last year.

Other News

Georgia Tech selects Sivakumar
Raghupathy “Siva” Sivakumar has been appointed as the university’s inaugural vice-president of commercialisation and chief commercialisation officer.
Daily deal net: September 13, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Lexeo Therapeutics bags $100m
Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.
Daily deal net: September 10, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Penn produces iEcure with $50m
Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.
Emulate models $82m series E
Harvard spinout Emulate will use the cash to further develop its organ-on-a-chip technology, having now raised nearly $225m in total.

Editor's Picks

Aerovate accesses public markets
Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Editorial: For the good of investors
As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
test reg

Login